HeAL3D: Heuristical-enhanced Active Learning for 3D Object Detection
Esteban Rivera, Surya Prabhakaran, Markus Lienkamp
TL;DR
HeAL tackles the challenge of label-efficient 3D object detection for autonomous driving by introducing a heuristically informed active-learning strategy. It combines localization- and classification-based uncertainty with augmentation-based inconsistency, using Gaussian mixture models to generate robust heatmaps that guide sample selection. Classwise probability maps and distance/point-density corrections further refine uncertainty estimation, enabling the method to prioritize informative distant or sparse-object samples. Across KITTI and nuScenes, HeAL achieves competitive or superior 3D mAP with substantially fewer labeled examples, highlighting practical impact for scalable real-world deployment and suggesting a complementary multi-strategy AL workflow for diverse data regimes.
Abstract
Active Learning has proved to be a relevant approach to perform sample selection for training models for Autonomous Driving. Particularly, previous works on active learning for 3D object detection have shown that selection of samples in uncontrolled scenarios is challenging. Furthermore, current approaches focus exclusively on the theoretical aspects of the sample selection problem but neglect the practical insights that can be obtained from the extensive literature and application of 3D detection models. In this paper, we introduce HeAL (Heuristical-enhanced Active Learning for 3D Object Detection) which integrates those heuristical features together with Localization and Classification to deliver the most contributing samples to the model's training. In contrast to previous works, our approach integrates heuristical features such as object distance and point-quantity to estimate the uncertainty, which enhance the usefulness of selected samples to train detection models. Our quantitative evaluation on KITTI shows that HeAL presents competitive mAP with respect to the State-of-the-Art, and achieves the same mAP as the full-supervised baseline with only 24% of the samples.
